Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Acute myeloid leukemia: the challenge of capturing disease variety Lowenberg BHematology Am Soc Hematol Educ Program 2008[]; ä (ä): 1-11The difference between success and failure of treatment of acute myeloid leukemia (AML) is largely determined by genotypic leukemia-specific differences among patients. The diversity of AML genotypes result from somatic genetic alterations settling down in succession in an individual's leukemia clone during the development of the disease. Gene mutations, gene expression abnormalities and other molecular alterations (e.g., microRNA variations) affect critical functions in AML cells, and may exert profound effects on the therapeutic response and outcome of the disease. Prototypes of common clinically significant gene aberrations involve transcription factors, signaling molecules and growth factor receptors. The expanding knowledge in this area allowing for risk stratified therapy decisions and the development of targeted drug therapy, is becoming an increasingly important part of the modern individualized clinical management of AML. This chapter highlights recent insights into the diagnostic, prognostic and therapeutic impact of chromosomal (e.g., the so-called monosomal karyotype) as well as particular genomic abnormalities, and presents examples of decision algorithms for individualized therapy.|Comparative Genomic Hybridization[MESH]|DNA-Binding Proteins/genetics[MESH]|Gene Expression Profiling[MESH]|Gene Expression Regulation, Neoplastic[MESH]|Genetic Markers[MESH]|Genetic Variation[MESH]|Genome, Human[MESH]|Genotype[MESH]|Humans[MESH]|Leukemia, Myeloid, Acute/classification/diagnosis/*genetics/therapy[MESH]|MDS1 and EVI1 Complex Locus Protein[MESH]|MicroRNAs/genetics[MESH]|Mutation[MESH]|Polymorphism, Single Nucleotide[MESH]|Proto-Oncogenes/genetics[MESH]|RNA, Messenger/genetics[MESH]|RNA, Neoplasm/genetics[MESH]|Transcription Factors/genetics[MESH]|Transcription, Genetic[MESH] |
